Abstract:We performed this systematic review and meta-analysis to evaluate the association between antioxidant supplementation and PCOS patients. The following databases were searched through March 2023: PubMed, Embase, The Cochrane Library, and Web of Science. This study included a total of 49 articles and 62 studies, and the sample consisted of 1657 PCOS patients from the antioxidant group and 1619 PCOS patients from the placebo group. The meta-analysis revealed that fasting blood glucose (FBG) levels (standardized squared variance (SMD)): -0.31 [95% CI: -0.39,- 0.22], p < 0.00001), the steady-state model assessment of insulin resistance(HOMA-IR) (SMD: -0.68 [95%, -0.87, -0.50], p < 0.00001) and insulin levels (SMD): -0.68 [95%, -0.79, -0.58], p <0.00001) in PCOS patients taking antioxidants were significantly lower than those in the placebo group. Compared with the placebo group, total cholesterol (TC) levels (SMD: -0.38[95%:-0.56,-0.20], p<0.001), low-density lipoprotein (LDL-C) levels (SMD: -0.24 [95%:-0.37, -0.10], p = 0.0008) and very low-density lipoprotein (VLDL) levels (SMD: -0.53 [95%:-0.65, -0.41], p < 0.00001) is lower in PCOS patients taking antioxidant supplements. Total testosterone (TT)(SMD:-0.78[95%:-1.15,-0.42],p<0.0001),dehydroepiandrosterone(DHEAS)(SMD:-0.42[95%:-0.58,-0.25],p<0.00001), and MF-G SCORES (SMD:-0.63[95%:-0.98,-0.28], p=0.0004) in patients taking antioxidant supplements is lower residually. C-reactive protein (CRP) levels (SMD:-0.48[95%: -0.63, -0.34], p < 0.000001), BMI (MD: -0.27[95%, -0.50, -0.03], p = 0.03), weight (MD: -0.73[95%, -1.35, -0.11, p = 0.02), diastolic blood pressure (MD: -3.78 [95%: -6.30,-1.26], p =0.003) is significantly lower. In addition, compared with the placebo group, The sex hormone binding protein (SHBG) level (SMD:0.23[95%:0.07,0.38], p=0.004), high-density lipoprotein (HDL-C)level (SMD:0.11[95%:0.01,0.20], p=0.03), total antioxidant capacity (TAC) level (SMD:0.59[95%:0.31,0.87], p<0.0001) and quantitative insulin sensitivity index (QUICKI) level (MD:0.01[95%:0.01,0.02], p <0.00001) were higher of PCOS patients who took antioxidant supplements. Antioxidant supplements did not affect other analyzed parameters in PCOS patients, including follicle-stimulating hormone (FSH), free androgen index (FAI), NO, glutathione (GSH), malondialdehyde (MDA), and diastolic blood pressure (DBP). Our study may provide a new treatment strategy for clinical PCOS patients, and more high-quality trials are expected to be carried out, especially for PCOS patients in Western countries, where lacks trials of antioxidant intervention in PCOS patients.

The impact of a standardized micronutrient supplementation on PCOS-typical parameters: a randomized controlled trial

Effects of single-dose and co-supplementation of vitamin D and omega-3 on metabolic profile in women with polycystic ovary syndrome: An RCT

The influences of vitamin D and omega-3 co-supplementation on clinical, metabolic and genetic parameters in women with polycystic ovary syndrome

The Effects of Omega-3 Fatty Acids and Vitamin E Co-Supplementation on Indices of Insulin Resistance and Hormonal Parameters in Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial

Micronutrients in support to the one carbon cycle for the modulation of blood fasting homocysteine in PCOS women

The Effects of Magnesium and Vitamin E Co-Supplementation on Hormonal Status and Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome

The Effects of Magnesium and Zinc Co-Supplementation on Biomarkers of Inflammation and Oxidative Stress, and Gene Expression Related to Inflammation in Polycystic Ovary Syndrome: a Randomized Controlled Clinical Trial

Omega-3 supplementation in the treatment of polycystic ovary syndrome (PCOS) - a review of clinical trials and cohort

The effectiveness of coenzyme Q10, vitamin E, inositols, and vitamin D in improving the endocrine and metabolic profiles in women with polycystic ovary syndrome: a network Meta-analysis

The effects of probiotic and selenium co-supplementation on parameters of mental health, hormonal profiles, and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome

Omega-3 and vitamin E co-supplementation can improve antioxidant markers in obese/overweight women with polycystic ovary syndrome

Efficacy of Antioxidant Supplementation in Improving Endocrine, Hormonal, Inflammatory, and Metabolic Statuses of PCOS: A Meta-analysis and Systematic Review

Hormonal and Metabolic Effects of Coenzyme Q10 and/or Vitamin E in Patients With Polycystic Ovary Syndrome

The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein(a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome

Comparison of nutritional supplements in improving glycolipid metabolism and endocrine function in polycystic ovary syndrome: a systematic review and network meta-analysis

Effects of nutrition on metabolic and endocrine outcomes in women with polycystic ovary syndrome: an umbrella review of meta-analyses of randomized controlled trials

The effects of omega-3 and vitamin E co-supplementation on parameters of mental health and gene expression related to insulin and inflammation in subjects with polycystic ovary syndrome

An overview on effects of micronutrients and macronutrients interventions in management of polycystic ovary syndrome

A meta-analysis of effects of vitamin E supplementation alone and in combination with omega-3 or magnesium on polycystic ovary syndrome

Evaluation of the efficacy of an antioxidant combination for the modulation of metabolic, endocrine, and clinical parameters in patients with polycystic ovary syndrome

The Effect of Magnesium and Vitamin E Co-Supplementation on Glycemic Control and Markers of Cardio-Metabolic Risk in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial